Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimitrakoudis, D.
Right arrow Articles by Bril, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimitrakoudis, D.
Right arrow Articles by Bril, V.
Related Collections
Right arrow Endocrine
Right arrow All Neuromuscular Disease
Right arrow Peripheral neuropathy

Neurology 2002;59:611-613
© 2002 American Academy of Neurology


Brief Communications

Comparison of sensory testing on different toe surfaces: Implications for neuropathy screening

Dimitri Dimitrakoudis, MD and Vera Bril, MD FRCPC

From the University Health Network, Toronto General Hospital, University of Toronto, Ontario, Canada.

Address correspondence and reprint requests to Dr. Vera Bril, EN 11-209, Toronto General Hospital, University Health Network, 200 Elizabeth St., Toronto, Ontario, Canada; e-mail: vera.bril{at}utoronto.ca

Successful screening for neuropathy in patients with diabetes is available using the 10 g Semmes–Weinstein monofilament (Mid-Delta Health Systems, Inc., Belzoni, MS) (touch/pressure sensation) and the Neurothesiometer (Horwell Scientific, London, UK; vibration perception threshold). In healthy volunteers and patients with a broad range of diabetic sensorimotor neuropathy, we show that the predictive value of either test for diabetic sensorimotor neuropathy depends on the toe surface tested. These results establish the importance of standardized screening methods for diabetic sensorimotor neuropathy in the clinic and in clinical research trials.




This article has been cited by other articles:


Home page
NeurologyHome page
P. J. Dyck
Enumerating Meissner corpuscles: Future gold standard of large fiber sensorimotor polyneuropathy?
Neurology, December 4, 2007; 69(23): 2116 - 2118.
[Full Text] [PDF]